Publications 2016

Publikationsliste Steno Diabetes Center 2016

Peer reviewed scientific papers

1. Abels M, Riva M, Bennet H, Ahlqvist E, Dyachok O, Nagaraj V, et al. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion. Diabetologia. 2016;59(9):1928-37.

2. Agesen RM, Kristensen PL, Beck-Nielsen H, Norgaard K, Perrild H, Christiansen JS, et al. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial. Diabetes & Metabolism. 2016;42(4):249-55.

3. Ahluwalia TS, Troelsen JT, Balslev-Harder M, Bork-Jensen J, Thuesen BH, Cerqueira C, et al. Carriers of a VEGFA enhancer polymorphism selectively binding CHOP/DDIT3 are predisposed to increased circulating levels of thyroid-stimulating hormone. J Med Genet. 2016.

4. Aho V, Ollila HM, Kronholm E, Bondia-Pons I, Soininen P, Kangas AJ, et al. Prolonged sleep restriction induces changes in pathways involved in cholesterol metabolism and inflammatory responses. Scientific Reports. 2016;6:14.

5. Ali A, Varga TV, Stojkovic IA, Schulz CA, Hallmans G, Barroso I, et al. Do Genetic Factors Modify the Relationship Between Obesity and Hypertriglyceridemia?: Findings From the GLACIER and the MDC Studies. Circulation-Cardiovascular Genetics. 2016;9(2):162-71.

6. Andersen GS, Kamper-Jorgensen Z, Carstensen B, Norredam M, Bygbjerg IC, Jorgensen ME. Diabetes among migrants in Denmark: Incidence, mortality, and prevalence based on a longitudinal register study of the entire Danish population. Diabetes Res Clin Pract. 2016;122:9-16.

7. Andersen MK, Jorsboe E, Sandholt CH, Grarup N, Jorgensen ME, Færgeman NJ, et al. Identification of Novel Genetic Determinants of Erythrocyte Membrane Fatty Acid Composition among Greenlanders. Plos Genetics. 2016;12(6):19.

8. Bang-Berthelsen CH, Holm TL, Pyke C, Simonsen L, Sokilde R, Pociot F, et al. GLP-1 Induces Barrier Protective Expression in Brunner's Glands and Regulates Colonic Inflammation. Inflammatory Bowel Diseases. 2016;22(9):2078-97.

9. Barban N, Jansen R, de Vlaming R, Vaez A, Mandemakers JJ, Tropf FC, et al. Genome-wide analysis identifies 12 loci influencing human reproductive behavior. Nature Genetics. 2016;48(12):1462-72.

10. Barfod K, Ejbye-Ernst N, Mygind L, Bentsen P. Increased provision of udeskole in Danish schools: An updated national population survey. Urban Forestry & Urban Greening. 2016;20:277-81.

11. Bentzen SMR, Knudsen VK, Christiensen T, Ewers B. Relative validity of a web-based food frequency questionnaire for patients with type 1 and type 2 diabetes in Denmark. Nutrition & diabetes. 2016;6(9):e232-e.

12. Berglund LM, Lyssenko V, Ladenvall C, Kotova O, Edsfeldt A, Pilgaard K, et al. Glucose-Dependent Insulinotropic Polypeptide Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB. Diabetes. 2016;65(1):239-54.

13. Biering-Sorensen T, Jensen JS, Andersen HU, Rossing P, Jensen MT. Cardiac time intervals and the association with 2D-speckle-tracking, tissue Doppler and conventional echocardiography: the Thousand&1 Study. International Journal of Cardiovascular Imaging. 2016;32(5):789-98.

14. Broholm C, Olsson A, Perfilyev A, Hansen NS, Schrolkamp M, Strasko KS, et al. Epigenetic programming of adipose-derived stem cells in low birthweight individuals. Diabetologia. 2016;59(12):2664-73.

15. Brons C, Lilleore SK, Astrup A, Vaag A. Disproportionately increased 24-h energy expenditure and fat oxidation in young men with low birth weight during a high-fat overfeeding challenge. European Journal of Nutrition. 2016;55(6):2045-52.

16. Brons C, Saltbaek PN, Friedrichsen M, Chen Y, Vaag A. Endocrine and metabolic diurnal rhythms in young adult men born small vs appropriate for gestational age. European Journal of Endocrinology. 2016;175(1):29-40.

17. Bruselius-Jensen M, Christensen JH, Bonde AH. Promoting Health Literacy in the Classroom. Health Education Journal. 2016.

18. Bruselius-Jensen M, Renwick K, Aagaard-Hansen J. Cross-cultural School Based Encounters as Health Education. Health Education Journal. 2016.

19. Buchebner D, McGuigan F, Gerdhem P, Ridderstrale M, Akesson K. Association Between Hypovitaminosis D in Elderly Women and Long- and Short-Term Mortality-Results from the Osteoporotic Prospective Risk Assessment Cohort. Journal of the American Geriatrics Society. 2016;64(5):990-7.

20. Bus SA, van Netten JJ, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, et al. IWGDF guidance on the prevention of foot ulcers in at-risk patients with diabetes. Diabetes-Metabolism Research and Reviews. 2016;32:16-24.

21. Caesar R, Nygren H, Oresic M, Backhed F. Interaction between dietary lipids and gut microbiota regulates hepatic cholesterol metabolism. Journal of Lipid Research. 2016;57(3):474-81.

22. Carstensen B, Read SH, Friis S, Sund R, Keskimaki I, Svensson AM, et al. Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals. Diabetologia. 2016;59(5):980-8.

23. Cavan DA, Ziegler R, Cranston I, Barnard K, Ryder J, Vogel C, et al. Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? NCT01460446. Bmc Family Practice. 2012;13.

24. Christensen DL, Faurholt-Jepsen D, Birkegaard L, Mwaniki DL, Boit MK, Kilonzo B, et al. Cardiovascular risk factors in rural Kenyans are associated with differential age gradients, but not modified by sex or ethnicity. Annals of Human Biology. 2016;43(1):42-9.

25. Christensen JH, Bonnelycke J, Mygind L, Bentsen P. Museums and science centres for health: from scientific literacy to health promotion. Museum Management and Curatorship. 2016;31(1):17-47.

26. Christian HE, Villanueva K, Klinker CD, Knuiman MW, Divitini M, Giles-Corti B. The effect of siblings and family dog ownership on children's independent mobility to neighbourhood destinations. Australian and New Zealand Journal of Public Health. 2016;40(4):316-8.

27. Cigliola V, Populaire C, Pierri CL, Deutsch S, Haefliger JA, Fadista J, et al. A Variant of GJD2, Encoding for Connexin 36, Alters the Function of Insulin Producing beta-Cells. Plos One. 2016;11(3):17.

28. Concillado M, Lund-Andersen H, Mathiesen ER, Larsen M. Dexamethasone Intravitreal Implant for Diabetic Macular Edema During Pregnancy. American Journal of Ophthalmology. 2016;165:7-15.

29. Currie G, Taylor AHM, Fujita T, Ohtsu H, Lindhardt M, Rossing P, et al. Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. Bmc Nephrology. 2016;17:14.

30. Davies MJ, Bain SC, Atkin SL, Rossing P, Scott D, Shamkhalova MS, et al. Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment ( LIRA-RENAL): A Randomized Clinical Trial. Diabetes Care. 2016;39(2):222-30.

31. de Vries PS, Chasman DI, Sabater-Lleal M, Chen MH, Huffman JE, Steri M, et al. A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration. Hum Mol Genet. 2016;25(2):358-70.

32. Deichgraeber P, Witte DR, Moller HJ, Skriver MV, Richelsen B, Jorgensen ME, et al. Soluble CD163, adiponectin, C-reactive protein and progression of dysglycaemia in individuals at high risk of type 2 diabetes mellitus: the ADDITION-PRO cohort. Diabetologia. 2016;59(11):2467-76.

33. Dejgaard TF, Frandsen CS, Hansen TS, Almdal T, Urhammer S, Pedersen-Bjergaard U, et al. Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial. Lancet Diabetes & Endocrinology. 2016;4(3):221-32.

34. Dejgaard TF, Frandsen CS, Holst JJ, Madsbad S. Liraglutide for treating type 1 diabetes. Expert Opinion on Biological Therapy. 2016;16(4):579-90.

35. Dhana K, van Rosmalen J, Vistisen D, Ikram MA, Hofman A, Franco OH, et al. Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis. European Journal of Epidemiology. 2016;31(6):583-92.

36. Do NC, Secher AL, Cramon P, Ringholm L, Watt T, Damm P, et al. Quality of life, anxiety and depression symptoms in early and late pregnancy in women with pregestational diabetes. Acta Obstet Gynecol Scand. 2016.

37. Donkin I, Versteyhe S, Ingerslev LR, Qian K, Mechta M, Nordkap L, et al. Obesity and Bariatric Surgery Drive Epigenetic Variation of Spermatozoa in Humans. Cell Metabolism. 2016;23(2):369-78.

38. Dooley J, Tian L, Schonefeldt S, Delghingaro-Augusto V, Garcia-Perez JE, Pasciuto E, et al. Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes. Nature Genetics. 2016;48(5):519-+.

39. Dreher JC, Dunne S, Pazderska A, Frodl T, Nolan JJ, O'Doherty JP. Testosterone causes both prosocial and antisocial status-enhancing behaviors in human males. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(41):11633-8.

40. Drobnjak D, Munch IC, Glumer C, Færch K, Kessel L, Larsen M, et al. Retinal Vessel Diameters and Their Relationship with Cardiovascular Risk and All-Cause Mortality in the Inter99 Eye Study: A 15-Year Follow-Up. Journal of ophthalmology. 2016;2016:6138659.

41. Due-Christensen M, Hommel E, Ridderstrale M. Potential positive impact of group-based diabetes dialogue meetings on diabetes distress and glucose control in people with type 1 diabetes. Patient education and counseling. 2016;99(12):1978-83.

42. Engelbrechtsen L, Iepsen EPW, Andersson EA, Mahendran Y, Lundgren J, Jonsson AE, et al. Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels. Metabolomics. 2016;12(12):9.

43. Felix JF, Bradfield JP, Monnereau C, van der Valk RJP, Stergiakouli E, Chesi A, et al. Genome-wide association analysis identifies three new susceptibility loci for childhood body mass index. Human Molecular Genetics. 2016;25(2):389-403.

44. Frandsen CS, Dejgaard TF, Madsbad S. Non-insulin drugs to treat hyperglycaemia in type 1 diabetes mellitus. Lancet Diabetes & Endocrinology. 2016;4(9):766-80.

45. Franklin SS, Thijs L, Asayama K, Li Y, Hansen TW, Boggia J, et al. The Cardiovascular Risk of White-Coat Hypertension. Journal of the American College of Cardiology. 2016;68(19):2033-43.

46. Friis K, Lasgaard M, Rowlands G, Osborne RH, Maindal HT. Health Literacy Mediates the Relationship Between Educational Attainment and Health Behavior: A Danish Population-Based Study. Journal of health communication. 2016;21(sup2):54-60.

47. Friis K, Vind BD, Simmons RK, Maindal HT. The Relationship between Health Literacy and Health Behaviour in People with Diabetes: A Danish Population-Based Study. Journal of Diabetes Research. 2016:7.

48. Fuchsberger C, Flannick J, Teslovich TM, Mahajan A, Agarwala V, Gaulton KJ, et al. The genetic architecture of type 2 diabetes. Nature. 2016;536(7614):41-+.

49. Færch K, Vistisen D, Pacini G, Torekov SS, Johansen NB, Witte DR, et al. Insulin Resistance Is Accompanied by Increased Fasting Glucagon and Delayed Glucagon Suppression in Individuals With Normal and Impaired Glucose Regulation. Diabetes. 2016;65(11):3473-81.

50. Geidenstam N, Danielsson APH, Spegel P, Ridderstrale M. Changes in glucose-elicited blood metabolite responses following weight loss and long term weight maintenance in obese individuals with impaired glucose tolerance. Diabetes Research and Clinical Practice. 2016;113:187-97.

51. Girma T, Kaestel P, Workeneh N, Molgaard C, Eaton S, Andersen GS, et al. Bioimpedance index for measurement of total body water in severely malnourished children: Assessing the effect of nutritional oedema. Clinical Nutrition. 2016;35(3):713-7.

52. Grytnes R, Shibuya H, Dyreborg J, Gron S, Cleal B. Too individualistic for safety culture? Non-traffic related work safety among heavy goods vehicle drivers. Transportation Research Part F-Traffic Psychology and Behaviour. 2016;40:145-55.

53. Gæde P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving HH, et al. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetologia. 2016;59(11):2298-307.

54. Hansen CS, Fleischer J, Vistisen D, Ridderstrale M, Jensen JS, Jorgensen ME. High and low vitamin D level is associated with cardiovascular autonomic neuropathy in people with Type 1 and Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association. 2016.

55. Hansen CS, Fleischer J, Vistisen D, Ridderstrale M, Jensen JS, Jorgensen ME. Reply to Kurtoglu, Association of heart rate variability with diabetes and vitamin D levels. Diabet Med. 2016.

56. Hansen CS, Jensen JS, Ridderstrale M, Vistisen D, Jorgensen ME, Fleischer J. Vitamin B12 deficiency is associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes. J Diabetes Complications. 2017;31(1):202-8.

57. Hansen NS, Hjort L, Broholm C, Gillberg L, Schrolkamp M, Schultz HS, et al. Metabolic and Transcriptional Changes in Cultured Muscle Stem Cells from Low Birth Weight Subjects. Journal of Clinical Endocrinology & Metabolism. 2016;101(5):2254-64.

58. Hargreave M, Kjaer SK, Jorgensen ME, Jensen A. Type 1 diabetes risk in children born to women with fertility problems: a cohort study in 1.5 million Danish children. Acta Obstetricia Et Gynecologica Scandinavica. 2016;95(12):1441-6.

59. Hartmeyer R, Stevenson MP, Bentsen P. Evaluating design-based formative assessment practices in outdoor science teaching. Educational Research. 2016;58(4):420-41.

60. Heerspink HJL, Ninomiya T, Persson F, Brenner BM, Brunel P, Chaturvedi N, et al. Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial. Diabetes Obesity & Metabolism. 2016;18(2):169-77.

61. Heerspink HJL, Person F, Brenner BM, Chaturvedi N, Brunel P, McMurray JJ, et al. Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial. Lancet Diabetes & Endocrinology. 2016;4(4):309-17.

62. Hempler NF, Joensen LE, Willaing I. Relationship between social network, social support and health behaviour in people with type 1 and type 2 diabetes: cross-sectional studies. Bmc Public Health. 2016;16:7.

63. Herder C, Færch K, Carstensen-Kirberg M, Lowe GD, Haapakoski R, Witte DR, et al. Biomarkers of subclinical inflammation and increases in glycaemia, insulin resistance and beta-cell function in non-diabetic individuals: the Whitehall II study. European Journal of Endocrinology. 2016;175(5):367-77.

64. Hindhede AL. Neighbourhood renewal, participation, and social capital in deprived areas: unintended consequences in a Nordic context. European Societies. 2016;18(5):535-59.

65. Hindhede AL, Bonde A, Schipperijn J, Scheuer SH, Sorensen SM, Aagaard-Hansen J. How do socio-economic factors and distance predict access to prevention and rehabilitation services in a Danish municipality? Primary Health Care Research and Development. 2016;17(6):578-85.

66. Hjortkjaer HO, Jensen T, Kofoed KF, Mogensen UM, Sigvardsen PE, Kober L, et al. Nocturnal antihypertensive treatment in patients with type 1 diabetes with autonomic neuropathy and non-dipping: a randomised, placebo-controlled, double-blind cross-over trial. BMJ Open. 2016;6(12):e012307.

67. Holst S, Kjaer SK, Jorgensen ME, Damm P, Jensen A. Fertility problems and risk of gestational diabetes mellitus: a nationwide cohort study. Fertility and Sterility. 2016;106(2):427-U251.

68. Hommel E, Schmidt S, Vistisen D, Neergaard K, Gribhild M, Almdal T, et al. Effects of advanced carbohydrate counting guided by an automated bolus calculator in Type 1 diabetes mellitus (StenoABC): a 12-month, randomized clinical trial. Diabetic medicine : a journal of the British Diabetic Association. 2016.

69. Horikoshi M, Beaumont RN, Day FR, Warrington NM, Kooijman MN, Fernandez-Tajes J, et al. Genome-wide associations for birth weight and correlations with adult disease. Nature. 2016;538(7624):248-+.

70. Hulman A, Simmons RK, Vistisen D, Tabak AG, Dekker JM, Alssema M, et al. Heterogeneity in glucose response curves during an oral glucose tolerance test and associated cardiometabolic risk. Endocrine. 2016.

71. Hyotylainen T, Jerby L, Petaja EM, Mattila I, Jantti S, Auvinen P, et al. Genome-scale study reveals reduced metabolic adaptability in patients with non-alcoholic fatty liver disease. Nature Communications. 2016;7:9.

72. Hyotylainen T, Oresic M. Bioanalytical techniques in nontargeted clinical lipidomics. Bioanalysis. 2016;8(4):351-64.

73. Imamura M, Takahashi A, Yamauchi T, Hara K, Yasuda K, Grarup N, et al. Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes. Nature Communications. 2016;7:12.

74. Ishtiak-Ahmed K, Carstensen B, Pedersen-Bjergaard U, Jorgensen ME. Incidence Trends and Predictors of Hospitalization for Hypoglycemia in 17,230 Adult Patients With Type 1 Diabetes: A Danish Register Linkage Cohort Study. Diabetes Care. 2016.

75. Jensen MT, Andersen HU, Rossing P, Jensen JS. Statins are independently associated with increased HbA1c in type 1 diabetes - The Thousand & 1 Study. Diabetes Research and Clinical Practice. 2016;111:51-7.

76. Jensen MT, Risum N, Rossing P, Jensen JS. Self-reported dyspnea is associated with impaired global longitudinal strain in ambulatory type 1 diabetes patients with normal ejection fraction and without known heart disease - The Thousand & 1 Study. Journal of Diabetes and Its Complications. 2016;30(5):928-34.

77. Jensen MT, Sogaard P, Andersen HU, Gustafsson I, Bech J, Hansen TF, et al. Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 study. Diabetes & Vascular Disease Research. 2016;13(4):260-7.

78. Jensen NK, Pals RA, Willaing I. The use of dialogue tools to promote dialogue-based and person-centred patient education for people with type 2 diabetes. Chronic illness. 2016;12(2):145-56.

79. Jensen TM, Vistisen D, Fleming T, Nawroth PP, Rossing P, Jorgensen ME, et al. Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus. Diabetic Medicine. 2016;33(12):1625-31.

80. Joensen LE, Almdal TP, Willaing I. Associations between patient characteristics, social relations, diabetes management, quality of life, glycaemic control and emotional burden in type 1 diabetes. Primary Care Diabetes. 2016;10(1):41-50.

81. Joensen LE, Filges T, Willaing I. Patient perspectives on peer support for adults with type 1 diabetes: a need for diabetes-specific social capital. Patient Preference and Adherence. 2016;10:1443-51.

82. Jones A, Olsen MZ, Perrild HJD, Willaing I. The psychological impact of living with diabetes: Descriptive findings from the DAWN2 study in Denmark. Primary Care Diabetes. 2016;10(1):83-6.

83. Jorgensen ME, Kristensen JK, Reventlov Husted G, Cerqueira C, Rossing P. The Danish Adult Diabetes Registry. Clinical epidemiology. 2016;8:429-34.

84. Jorgensen PG, Jensen MT, Biering-Sorensen T, Mogelvang R, Galatius S, Fritz-Hansen T, et al. Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes. Cardiovascular Diabetology. 2016;15:11.

85. Jorgensen PG, Jensen MT, Mogelvang R, Fritz-Hansen T, Galatius S, Biering-Sorensen T, et al. Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function. International Journal of Cardiology. 2016;221:114-21.

86. Jorgensen PG, Jensen MT, Mogelvang R, von Scholten BJ, Bech J, Fritz-Hansen T, et al. Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics. Diabetes & Vascular Disease Research. 2016;13(5):321-30.

87. Jourdan D, Christensen JH, Darlington E, Bonde AH, Bloch P, Jensen BB, et al. The involvement of young people in school- and community-based noncommunicable disease prevention interventions: a scoping review of designs and outcomes. Bmc Public Health. 2016;16:14.

88. Jujic A, Nilsson PM, Persson M, Holst JJ, Torekov SS, Lyssenko V, et al. Atrial Natriuretic Peptide in the High Normal Range Is Associated With Lower Prevalence of Insulin Resistance. Journal of Clinical Endocrinology & Metabolism. 2016;101(4):1372-80.

89. Justesen JM, Andersson EA, Allin KH, Sandholt CH, Jorgensen T, Linneberg A, et al. Increasing insulin resistance accentuates the effect of triglyceride-associated loci on serum triglycerides during 5 years. Journal of Lipid Research. 2016;57(12):2193-9.

90. Kelstrup L, Dejgaard TF, Clausen TD, Mathiesen ER, Hansen T, Vestergaard H, et al. Levels of the inflammation marker YKL-40 in young adults exposed to intrauterine hyperglycemia. Diabetes Research and Clinical Practice. 2016;114:50-4.

91. Kilpelainen TO, Carli JFM, Skowronski AA, Sun Q, Kriebel J, Feitosa MF, et al. Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nature Communications. 2016;7:14.

92. Klefter ON, Hommel E, Munch IC, Norgaard K, Madsbad S, Larsen M. Retinal characteristics during 1year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study. Acta Ophthalmologica. 2016;94(6):540-7.

93. Kure-Biegel N, Schnohr CW, Hindhede AL, Diderichsen F. Risk factors for not completing health interventions and the potential impact on health inequalities between educational groups - a mixed method study from Denmark. International Journal for Equity in Health. 2016;15:8.

94. Kurko J, Tringham M, Tanner L, Nanto-Salonen K, Vaha-Makila M, Nygren H, et al. Imbalance of plasma amino acids, metabolites and lipids in patients with lysinuric protein intolerance (LPI). Metabolism-Clinical and Experimental. 2016;65(9):1361-75.

95. Lankinen M, Schwab U, Kolehmainen M, Paananen J, Nygren H, Seppanen-Laakso T, et al. A Healthy Nordic Diet Alters the Plasma Lipidomic Profile in Adults with Features of Metabolic Syndrome in a Multicenter Randomized Dietary Intervention. Journal of Nutrition. 2016;146(4):662-72.

96. Larsen SC, Angquist L, Moldovan M, Huikari V, Sebert S, Cavadino A, et al. Serum 25-Hydroxyvitamin D Status and Longitudinal Changes in Weight and Waist Circumference: Influence of Genetic Predisposition to Adiposity. Plos One. 2016;11(4):18.

97. Larsen SC, Angquist L, Ostergaard JN, Ahluwalia TS, Vimaleswaran KS, Roswall N, et al. Intake of Total and Subgroups of Fat Minimally Affect the Associations between Selected Single Nucleotide Polymorphisms in the PPAR gamma Pathway and Changes in Anthropometry among European Adults from Cohorts of the DiOGenes Study. Journal of Nutrition. 2016;146(3):603-11.

98. Li M, Li Y, Weeks O, Mijatovic V, Teumer A, Huffman JE, et al. SOS2 and ACP1 Loci Identified through Large-Scale Exome Chip Analysis Regulate Kidney Development and Function. Journal of the American Society of Nephrology : JASN. 2016.

99. Lidegaard LP, Schwennesen N, Willaing I, Færch K. Barriers to and motivators for physical activity among people with Type 2 diabetes: patients' perspectives. Diabetic Medicine. 2016;33(12):1677-85.

100. Lind MV, Madsen ML, Rumessen JJ, Vestergaard H, Gabel RJ, Hansen T, et al. Plasma Alkylresorcinols Reflect Gluten Intake and Distinguish between Gluten-Rich and Gluten-Poor Diets in a Population at Risk of Metabolic Syndrome. Journal of Nutrition. 2016;146(10):1991-8.

101. Lindhardt M, Persson F, Currie G, Pontillo C, Beige J, Delles C, et al. Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial. Bmj Open. 2016;6(3):9.

102. Lindhardt M, Persson F, Zurbig P, Stalmach A, Mischak H, de Zeeuw D, et al. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2016.

103. Llargues E, Recasens MA, Manresa JM, Jensen BB, Franco R, Nadal A, et al. Four-year outcomes of an educational intervention in healthy habits in schoolchildren: the Avall 3 Trial. European journal of public health. 2016.

104. Loisel DA, Du G, Ahluwalia TS, Tisler CJ, Evans MD, Myers RA, et al. Genetic associations with viral respiratory illnesses and asthma control in children. Clinical and Experimental Allergy. 2016;46(1):112-24.

105. Lu YC, Day FR, Gustafsson S, Buchkovich ML, Na JB, Bataille V, et al. y New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nature Communications. 2016;7:15.

106. Lundby-Christensen L, Tarnow L, Boesgaard TW, Lund SS, Wiinberg N, Perrild H, et al. Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial. Bmj Open. 2016;6(2):11.

107. Lundby-Christensen L, Vaag A, Tarnow L, Almdal TP, Lund SS, Wetterslev J, et al. Effects of biphasic, basal-bolus or basal insulin analogue treatments on carotid intima-media thickness in patients with type 2 diabetes mellitus: the randomised Copenhagen Insulin and Metformin Therapy (CIMT) trial. Bmj Open. 2016;6(2):11.

108. Luukkonen PK, Zhou Y, Hyotylainen T, Leivonen M, Arola J, Orho-Melander M, et al. The MBOAT7 variant rs641738 alters hepatic phosphatidylinositols and increases severity of non-alcoholic fatty liver disease in humans. Journal of Hepatology. 2016;65(6):1263-5.

109. Luukkonen PK, Zhou Y, Sadevirta S, Leivonen M, Arola J, Oresic M, et al. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 2016;64(5):1167-75.

110. Lyssenko V, Bianchi C, Del Prato S. Personalized Therapy by Phenotype and Genotype. Diabetes Care. 2016;39:S127-S36.

111. Maindal HT, Kayser L, Norgaard O, Bo A, Elsworth GR, Osborne RH. Cultural adaptation and validation of the Health Literacy Questionnaire (HLQ): robust nine-dimension Danish language confirmatory factor model. Springerplus. 2016;5:16.

112. Marinkovic T, Oresic M. Modeling strategies to study metabolic pathways in progression to type 1 diabetes - Challenges and opportunities. Archives of Biochemistry and Biophysics. 2016;589:131-7.

113. Moller CL, Kjobsted R, Enriori PJ, Jensen TE, Garcia-Rudaz C, Litwak SA, et al. alpha-MSH Stimulates Glucose Uptake in Mouse Muscle and Phosphorylates Rab-GTPase-Activating Protein TBC1D1 Independently of AMPK. Plos One. 2016;11(7):18.

114. Moller CL, Vistisen D, Færch K, Johansen NB, Witte DR, Jonsson A, et al. Glucose-Dependent Insulinotropic Polypeptide Is Associated With Lower Low-Density Lipoprotein But Unhealthy Fat Distribution, Independent of Insulin: The ADDITION-PRO Study. Journal of Clinical Endocrinology & Metabolism. 2016;101(2):485-93.

115. Nexo BA, Villesen P, Nissen KK, Lindegaard HM, Rossing P, Petersen T, et al. Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci. Immunologic Research. 2016;64(1):55-63.

116. Nielsen G, Mygind E, Bolling M, Otte CR, Schneller MB, Schipperijn J, et al. A quasi-experimental cross-disciplinary evaluation of the impacts of education outside the classroom on pupils' physical activity, well-being and learning: the TEACHOUT study protocol. Bmc Public Health. 2016;16:15.

117. Nielsen HB, Ovesen LL, Mortensen LH, Lau CJ, Joensen LE. Type 1 diabetes, quality of life, occupational status and education level - A comparative population-based study. Diabetes Res Clin Pract. 2016;121:62-8.

118. Nielsen NO, Bjerregaard P, Ronn PF, Friis H, Andersen S, Melbye M, et al. Associations between Vitamin D Status and Type 2 Diabetes Measures among Inuit in Greenland May Be Affected by Other Factors. Plos One. 2016;11(4):13.

119. Noctor E, Dunne F. Re: Coustan "Follow-up of women with previous gestational diabetes" (comment on Noctor et al. ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria. Acta Diabetol 2015;52:153-160). Acta Diabetologica. 2016;53(1):135-6.

120. Norris SA, Ho JCC, Abd Rashed A, Vinding V, Skau JKH, Biesma R, et al. Pre-pregnancy community-based intervention for couples in Malaysia: application of intervention mapping. Bmc Public Health. 2016;16:7.

121. Nouhravesh N, Andersen HU, Jensen JS, Rossing P, Jensen MT. Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients - The Thousand & 1 Study. Diabetes Research and Clinical Practice. 2016;116:263-9.

122. Okbay A, Baselmans BML, De Neve JE, Turley P, Nivard MG, Fontana MA, et al. Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nature Genetics. 2016;48(6):624-+.

123. Okbay A, Beauchamp JP, Fontana MA, Lee JJ, Pers TH, Rietveld CA, et al. Genome-wide association study identifies 74 loci associated with educational attainment. Nature. 2016;533(7604):539-+.

124. Olsen NJ, Angquist L, Larsen SC, Linneberg A, Skaaby T, Husemoen LLN, et al. Interactions between genetic variants associated with adiposity traits and soft drinks in relation to longitudinal changes in body weight and waist circumference. American Journal of Clinical Nutrition. 2016;104(3):816-26.

125. Oresic M, Posti JP, Kamstrup-Nielsen MH, Takala RSK, Lingsma HF, Mattila I, et al. Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury. Ebiomedicine. 2016;12:118-26.

126. Pals RAS, Olesen K, Willaing I. What does theory-driven evaluation add to the analysis of self-reported outcomes of diabetes education? A comparative realist evaluation of a participatory patient education approach. Patient Education and Counseling. 2016;99(6):995-1001.

127. Pankratz N, Schick UM, Zhou Y, Zhou W, Ahluwalia TS, Allende ML, et al. Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits. Nature Genetics. 2016;48(8):867-+.

128. Parshintsev J, Hyotylainen T. Methods for characterization of organic compounds in atmospheric aerosol particles (vol 407, pg 5877, 2015). Analytical and Bioanalytical Chemistry. 2016;408(1):339-40.

129. Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376-+.

130. Pedersen ML, Olesen J, Jorgensen ME, Damm P. Gestational diabetes mellitus in Greenland: a national study of prevalence and testing efficacy. International Journal of Circumpolar Health. 2016;75:6.

131. Pedersen-Bjergaard U, Kristensen PL, Norgaard K, Perrild H, Jensen T, Thorsteinsson B, et al. Short-term cost-effectiveness of insulin detemir and insulin aspart in people with type 1 diabetes who are prone to recurrent severe hypoglycemia. Current Medical Research and Opinion. 2016;32(10):1719-25.

132. Pena MJ, Heinzel A, Rossing P, Parving HH, Dallmann G, Rossing K, et al. Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus. Journal of Translational Medicine. 2016;14:11.

133. Persson F, Lindhardt M, Rossing P, Parving HH. Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review. Journal of the Renin-Angiotensin-Aldosterone System. 2016;17(3):10.

134. Persson F, Theilade S, Eugen-Olsen J, Rossing P, Parving H-H. Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes. Journal of diabetes and its complications. 2016;30(8):1440-2.

135. Petrykiv SI, de Zeeuw D, Persson F, Rossing P, Gansevoort RT, Laverman GD, et al. Variability in response to albuminuria lowering drugs: true or random? British journal of clinical pharmacology. 2016.

136. Pontillo C, Jacobs L, Staessen JA, Schanstra JP, Rossing P, Heerspink HJ, et al. A urinary proteome-based classifier for the early detection of decline in glomerular filtration. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2016.

137. Rasmussen BSB, Yderstraede KB, Carstensen B, Skov O, Beck-Nielsen H. Substantial reduction in the number of amputations among patients with diabetes: a cohort study over 16 years. Diabetologia. 2016;59(1):121-9.

138. Rasmussen JB, Nordin LS, Thomsen JA, Rossing P, Bygbjerg IC, Christensen DL. Several Conventional Risk Markers Suggesting Presence of Albuminuria Are Weak Among Rural Africans With Hypertension. Journal of Clinical Hypertension. 2016;18(1):27-30.

139. Rasmussen SS, Johansen NB, Witte DR, Borch-Johnsen K, Sandbaek A, Lauritzen T, et al. Incidence of register-based diabetes 10 years after a stepwise diabetes screening programme: the ADDITION-Denmark study. Diabetologia. 2016;59(5):989-97.

140. Ridderstrale M, Evans LM, Jensen HH, Bogelund M, Jensen MM, Ericsson A, et al. Estimating the impact of changes in HbA(1c), body weight and insulin injection regimen on health related quality-of-life: a time trade off study. Health and Quality of Life Outcomes. 2016;14:10.

141. Ried JS, Jeff JM, Chu AY, Bragg-Gresham JL, van Dongen J, Huffman JE, et al. A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape. Nature Communications. 2016;7:11.

142. Ringholm L, Damm JA, Vestgaard M, Damm P, Mathiesen ER. Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding. Current Diabetes Reports. 2016;16(2):10.

143. Rocca-Serra P, Salek RM, Arita M, Correa E, Dayalan S, Gonzalez-Beltran A, et al. Data standards can boost metabolomics research, and if there is a will, there is a way. Metabolomics. 2016;12(1):13.

144. Roussel R, Natali A, Balkau B, Hojlund K, Sanchez G, Nolan JJ, et al. Beta-cell function is associated with carotid intima-media thickness independently of insulin resistance in healthy individuals. Journal of Hypertension. 2016;34(4):685-91.

145. Ruge D, Nielsen MK, Mikkelsen BE, Bruun-Jensen B. Examining participation in relation to students' development of health-related action competence in a school food setting LOMA case study. Health Education. 2016;116(1):69-85.

146. Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, et al. The Genetic Landscape of Renal Complications in Type 1 Diabetes. Journal of the American Society of Nephrology : JASN. 2016.

147. Scheuer SH, Færch K, Philipsen A, Jorgensen ME, Johansen NB, Carstensen B, et al. Response to the Letter: Comment on "Abdominal Fat Distribution and Cardiovascular Risk in Men and Women With Different Levels of Glucose Tolerance" by Scheuer S.H., et al. The Journal of clinical endocrinology and metabolism. 2016;101(2):L13-4.

148. Schmidt S, Norgaard K, Neergaard K, Almdal T, Hommel EE. Long-Term Adherence to Automated Bolus Calculators. Journal of diabetes science and technology. 2016.

149. Schnurr TM, Gjesing AP, Sandholt CH, Jonsson A, Mahendran Y, Have CT, et al. Genetic Correlation between Body Fat Percentage and Cardiorespiratory Fitness Suggests Common Genetic Etiology. Plos One. 2016;11(11):14.

150. Schwennesen N, Henriksen JE, Willaing I. Patient explanations for non-attendance at type 2 diabetes self-management education: a qualitative study. Scandinavian Journal of Caring Sciences. 2016;30(1):187-92.

151. Scott RA, Freitag DF, Li L, Chu AY, Surendran P, Young R, et al. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease. Science Translational Medicine. 2016;8(341):13.

152. Skau JKH, Nordin ABA, Cheah JCH, Ali R, Zainal R, Aris T, et al. A complex behavioural change intervention to reduce the risk of diabetes and prediabetes in the pre-conception period in Malaysia: study protocol for a randomised controlled trial. Trials. 2016;17:12.

153. Stenov V, Henriksen JE, Folker AP, Skinner TC, Willaing I. Educator talk ratio as a quality indicator in group-based patient education. Health Education Journal. 2016;75(3):259-69.

154. Stojkovic IA, Ericson U, Rukh G, Ridderstrale M, Romeo S, Orho-Melander M. The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levels (vol 9, pg 388, 2014). Genes and Nutrition. 2016;11:1.

155. Suvitaival T, Mantere O, Kieseppa T, Mattila I, Poho P, Hyotylainen T, et al. Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis. Translational psychiatry. 2016;6(11):e951.

156. Svendstrup M, Sandholt CH, Galijatovic EAA, Linneberg A, Jorgensen T, Sorensen TIA, et al. Genetic Risk Scores Link Body Fat Distribution with Specific Cardiometabolic Profiles. Obesity. 2016;24(8):1778-85.

157. Svensson AL, Christensen R, Persson F, Logstrup BB, Giraldi A, Graugaard C, et al. Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial. Bmj Open. 2016;6(4):13.

158. Theilade S, Claggett B, Hansen TW, Skali H, Lewis EF, Solomon SD, et al. Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia-the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). Journal of Human Hypertension. 2016;30(1):46-52.

159. Theilade S, Rossing P, Eugen-Olsen J, Jensen JS, Jensen MT. suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease. European Journal of Endocrinology. 2016;174(6):745-53.

160. van Netten JJ, Price PE, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, et al. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes-Metabolism Research and Reviews. 2016;32:84-98.

161. Vestmar MA, Andersson EA, Christensen CR, Hauge M, Glumer C, Linneberg A, et al. Functional and genetic epidemiological characterisation of the FFAR4 (GPR120) p.R270H variant in the Danish population. Journal of Medical Genetics. 2016;53(9):616-23.

162. Vetrani C, Rivellese AA, Annuzzi G, Adiels M, Boren J, Mattila I, et al. Metabolic transformations of dietary polyphenols: comparison between in vitro colonic and hepatic models and in vivo urinary metabolites. Journal of Nutritional Biochemistry. 2016;33:111-8.

163. Vishram JKK, Hansen TW, Torp-Pedersen C, Madsbad S, Jorgensen T, Fenger M, et al. Relationship Between Two Common Lipoprotein Lipase Variants and the Metabolic Syndrome and Its Individual Components. Metabolic Syndrome and Related Disorders. 2016;14(9):442-8.

164. Vistisen D, Andersen GS, Hansen CS, Hulman A, Henriksen JE, Bech-Nielsen H, et al. Prediction of First Cardiovascular Disease Event in Type 1 Diabetes Mellitus The Steno Type 1 Risk Engine. Circulation. 2016;133(11):1058-66.

165. Vitger T, Hempler NF. Mobile applications for management of Type 2 diabetes. Ugeskrift for laeger. 2016;178(33).

166. von Scholten BJ, Hansen CS, Hasbak P, Kjaer A, Rossing P, Hansen TW. Cardiac Autonomic Function Is Associated With the Coronary Microcirculatory Function in Patients With Type 2 Diabetes. Diabetes. 2016;65(10):3129-38.

167. von Scholten BJ, Hasbak P, Christensen TE, Ghotbi AA, Kjaer A, Rossing P, et al. Cardiac Rb-82 PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes. Diabetologia. 2016;59(2):371-8.

168. von Scholten BJ, Persson F, Rosenlund S, Hovind P, Faber J, Hansen TW, et al. The effect of liraglutide on renal function: A randomized clinical trial. Diabetes, obesity & metabolism. 2016.

169. von Scholten BJ, Reinhard H, Hansen TW, Oellgaard J, Parving HH, Jacobsen PK, et al. Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria. Diabetologia. 2016;59(7):1549-57.

170. von Scholten BJ, Reinhard H, Hansen TW, Schalkwijk CG, Stehouwer C, Parving HH, et al. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria. Journal of Diabetes and Its Complications. 2016;30(2):248-55.

171. von Scholten BJ, Rosendahl A, Hasbak P, Bergholdt R, Kjaer A, Rossing P, et al. Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R(+) T cells. Cardiovascular Diabetology. 2016;15:18.

172. Waite S, Bolling M, Bentsen P. Comparing apples and pears?: a conceptual framework for understanding forms of outdoor learning through comparison of English Forest Schools and Danish udeskole. Environmental Education Research. 2016;22(6):868-92.

173. Walford GA, Gustafsson S, Rybin D, Stancakova A, Chen H, Liu CT, et al. Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci. Diabetes. 2016;65(10):3200-11.

174. Winkler LL, Christensen U, Glumer C, Bloch P, Mikkelsen BE, Wansink B, et al. Substituting sugar confectionery with fruit and healthy snacks at checkout - a win-win strategy for consumers and food stores? a study on consumer attitudes and sales effects of a healthy supermarket intervention. Bmc Public Health. 2016;16:12.

175. Zampetaki A, Willeit P, Burr S, Yin XK, Langley SR, Kiechl S, et al. Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes. Diabetes. 2016;65(1):216-27.

176. Zhou Y, Oresic M, Leivonen M, Gopalacharyulu P, Hyysalo J, Arola J, et al. Noninvasive Detection of Nonalcoholic Steatohepatitis Using Clinical Markers and Circulating Levels of Lipids and Metabolites. Clinical Gastroenterology and Hepatology. 2016;14(10):1463-+.

177. Zobel EH, Hansen TW, Rossing P, von Scholten BJ. Global Changes in Food Supply and the Obesity Epidemic. Current Obesity Reports. 2016;5(4):449-55.

178. Zobel EH, von Scholten BJ, Lajer M, Jorsal A, Tarnow L, Rasmussen LM, et al. High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes. Journal of diabetes and its complications. 2016;30(8):1603-8.

179. Zobel EH, von Scholten BJ, Lindhardt M, Persson F, Hansen TW, Rossing P. Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment. Journal of diabetes and its complications. 2016.

Published abstracts for scientific conferences

1. Ba-Ali S, Valerius M, Hodzic-Hadzibegovic D, Tornes MH, Lund-Andersen H. Effect of Dexamethasone intravitreal implant, ozurdex (R), on diabetic macular oedema during pregnancy. European Journal of Ophthalmology. 2016;26(4):E110-E.

2. Christensen RH, Von Scholten BJ, Rosenmeier JB, Hansen CS, Ellingsgaard H, Reinhard H, et al. Epicardial adipose tissue and cardiovascular disease in type 2 diabetes. European Heart Journal. 2016;37:734-.

3. Due-Christensen M, Hommel E, Ridderstrale M. Group-based diabetes dialogue meetings with peers and healthcare professionals reduce diabetes-related distress and improve glycaemic control in people with Type 1 diabetes. Diabetic Medicine. 2016;33:118-.

4. Due-Christensen M, Hopkins D, Willaing I, Forbes A. Adults with new onset Type 1 diabetes: the process of adaptation. Diabetic Medicine. 2016;33:134-.

5. Grabowski D, Varming AR, Pals RAS, Andersen TH. Involvement of family members in life with Type 2 diabetes: a research and development project based on co-creation and design processes. Diabetic Medicine. 2016;33:117-.

6. Hansen UM, Cleal B, Tjørnhoj-Thomsen T, Willaing I. Type 1 diabetes in work life: A matter of containment? . International Journal of Behavioral Medicine. 2016;23:S228-S.

7. Hodzic-Hadzibegovic D, Sander B, Lund-Andersen H. Nonresponders in a group of unselected diabetes patients treated with ranibizumab for diabetic macular oedema. European Journal of Ophthalmology. 2016;26(4):E107-E.

8. Mayer G, Eder S, Rosivall L, Voros P, Heerspink HL, de Zeeuw D, et al. Baseline data from the multinational prospective cohort study for validation of biomarkers (Provalid). Nephrology Dialysis Transplantation. 2016;31:1482-.

9. O'Connell B, Boyle N, Oresic M, Hyotylainen T, Mattila I, Denvir K, et al. Assessment of blood biomarkers of mild traumatic brain injury in professional rugby; a case control study. Brain Injury. 2016;30(5-6):678-.

10. O'Gorman DJ, Kennedy A, Cobb J, O'Donoghue G, Anderson G, McCaffrey N, et al. The identification of novel metabolites that track with improvements in glycaemia following a 12-week lifestyle intervention in high risk individuals. Irish Journal of Medical Science. 2016;185:414-5.

11. Olesen K, Willaing I. Low sense of coherence is associated with elevated LDL cholesterol in people with Type 1 diabetes. Diabetic Medicine. 2016;33:134-.

12. Ridderstrale M, Fitchett D, Kis SG, Woerle HJ, Mattheus M, Zinman B, et al. Effect of empagliflozin on cardiovascular death in subgroups by age: results from EMPA-REG OUTCOME. European Heart Journal. 2016;37:1192-.

13. Roze S, Duteil E, Delbaere A, De Portu S, Brandt AS, Ridderstrale M. Projection of health-economic benefits of sensor-augmented pump (SAP) versus insulin pump therapy alone (CSII), in type 1 diabetes patients, in Denmark. Diabetes Technology & Therapeutics. 2016;18:A79-A80.

14. Tenovuo O, Ic MO, Posti J, Kamstrup-Nielsen M, Takala R, Lingsma H, et al. Human seerum metabolite associated with severity and patient outcomes in traumatic brain injury Journal of Neurotrauma. 2016;33(13):A83-A.

15. Thorning-Schmidt H, Glindorf M, Nielsen K, Lund-Andersen H, Valerius M. Nurse-led eye screening in a specialist diabetes clinic is cost-effective and has shown a reduction in visual impairment and blindness. European Journal of Ophthalmology. 2016;26(4):E90-E.

Book and book chapters

1. Asayama K, Wei F-F, Hara A, Hansen TW, Li Y, Staessen JA. Blood Pressure Variability as Elusive Harbinger of Adverse Health Outcomes. In: White WB, editor. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Cham: Springer International Publishing; 2016. p. 129-48.

2. Grønbæk M, Jensen BB, Reventlow S. Sundhedsfremme og forebyggelse. In: Jensen BB, Grønbæk M, Reventlow S, editors. Forebyggende Sundhedsarbejde. 6 ed. København: Munksgaard; 2016. p. 19-20.

3. Hempler NF, Pals RS, Pedersbæk L, Jensen S. Livsstilsguide i praksis. Sundhedspædagogisk samarbejde mellem professionelle og voksne med psykisk sygdom. 1 ed. København: Region Syddanmark, de 22 syddanske kommuner og Steno Diabetes Center; 2016 April. 52 p.

4. Hempler NF, Pals RS, Pedersbæk L, Jensen S. Inspiration til implementering af sundhedspædagogiske værktøjer – historier fra professionelle i Region Syddanmark. København: Region Syddanmark, de 22 syddanske kommuner og Steno Diabetes Center; 2016.

5. Jensen BB. Sundhedspædagogisk intervention. In: Jensen BB, Grønbæk M, Reventlow S, editors. Forebyggende sundhedsarbejde. 6 ed. København: Munksgaard; 2016. p. 327-54.

6. Jensen BB, Dür W, Buijs G. The Application of Salutogenesis in Schools. In: Mittelmark MB, Sagy S, Eriksson M, Bauer GF, Pelikan JM, Lindström B, et al., editors. The Handbook of Salutogenesis. Cham: Springer International Publishing; 2017. p. 225-35.

7. Reventlow S, Jensen BB, Grønbæk M, Kamper-Jørgensen F. Analysemodeller. In: Jensen BB, Grønbæk M, Reventlow S, editors. Forebyggende Sundhedsarbejde. 6 ed. København: Munksgaard; 2016. p. 41-8.

8. Varming A. Perspektiver på kostvejledning for grupper og familier. In: L N, editor. Kostvejledning – Teorier, metoder og perspektiver. 1 ed. København: Munksgaard; 2016.

Non peer reviewed papers

1. Hempler NF. Er der forskelle i sociale relationer blandt personer med type 1- og type 2-diabetes? . Best Practice Sygeplejersken [Internet]. 2016;5(18). Available from:

2. Lund-Andersen HH, L. H. Valerius, M. Ulrik A-M. . Telemedicinsk betjening af Grønland. Den teknologiske udvikling giver (næsten) uanede muligheder. Et samarbejde mellem Grønland og Rigshospitalet-Glostrup og Steno Diabetes Center. Oftalmolog. 2016(4):18-20. Available from:

Sidst opdateret 16-01-2017